Ultrasonographic Quantification of Hepatic–Renal Echogenicity Difference in Hepatic Steatosis Diagnosis

Background and AimUltrasound (US) is recommended for hepatic steatosis screening. The purpose of this study was to determine the usefulness of US hepatic-renal echo-intensity (HR) difference in the quantitative assessment of hepatic steatosis.MethodsConsecutive patients undergoing liver biopsy were prospectively enrolled. Using US histogram technique, the mean gray level of hepatic parenchyma and right renal parenchyma at selected regions of interest were evaluated on the same day of biopsy. With steatosis assessed by histology as the reference, the diagnostic performances of HR difference in predicting the degree of steatosis was analyzed. The optimal cut-off level, diagnostic validity and post-test probability were assessed.ResultsA total of 175 patients were enrolled (M/F, 103/72; mean age, 48.6 ± 11.7). There were 64 (36.5 %), 42 (24 %), 29 (16.6 %), 12 (6.9 %) and 28 (16 %) patients with steatosis of <5, 5–9, 10–19, 20–29 and ≥30 %, respectively. Multivariate analysis showed HR difference correlated with the severity of steatosis (R2 = 0.425, p < 0.001) with positive correlation between HR difference and the severity of steatosis (r = 0.60, p < 0.001). The diagnostic performances were 0.927, 0.890, 0.816 and 0.760 for steatosis ≥30, ≥20, ≥10 and ≥5 %, respectively. The cut-off is 7 for diagnosing steatosis ≥30 %, with a negative predictive value of 97.6 %. The cut-off is 4 in predicting steatosis ≥5 %, with a positive predictive value of 79 %. The prevalence of steatosis influenced the post-test probability.ConclusionsQuantitative assessment of HR difference with US histogram technique is useful in excluding moderate to severe hepatic steatosis.

[1]  C. Chu,et al.  Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection? , 2007, International Journal of Obesity.

[2]  H. Osawa,et al.  Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes , 1996, Journal of clinical ultrasound : JCU.

[3]  T. Lehenbauer,et al.  Quantification of hepatic and renal cortical echogenicity in clinically normal cats. , 2000, American journal of veterinary research.

[4]  Xi Jin,et al.  Association between Hepatic Steatosis and Entecavir Treatment Failure in Chinese Patients with Chronic Hepatitis B , 2012, PloS one.

[5]  F. Schick,et al.  Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. , 2009, Journal of hepatology.

[6]  Eliseo Guallar,et al.  Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta‐analysis , 2011, Hepatology.

[7]  M. Yalnız,et al.  Impact of liver steatosis on response to pegylated interferon therapy in patients with chronic hepatitis B. , 2011, World journal of gastroenterology.

[8]  Sheng-Nan Lu,et al.  Impact of Steatosis on Long-Term Histological Outcome in Chronic Hepatitis C after Antiviral Therapy , 2005, Antiviral therapy.

[9]  A. Craxì,et al.  Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[10]  V. de Lédinghen,et al.  Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. , 2010, Ultrasound in medicine & biology.

[11]  Meng-Su Zeng,et al.  Standardized Ultrasound Hepatic/Renal Ratio and Hepatic Attenuation Rate to Quantify Liver Fat Content: An Improvement Method , 2011, Obesity.

[12]  P. Giral,et al.  Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.

[13]  A. Pollett,et al.  Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[14]  A. Baranova,et al.  Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults , 2011, Alimentary pharmacology & therapeutics.

[15]  Marco Salvatore,et al.  Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy. , 2009, Metabolism: clinical and experimental.

[16]  E. Lawitz,et al.  The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: A retrospective observational study , 2005, BMC gastroenterology.

[17]  Zamir Halpern,et al.  Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. , 2009, AJR. American journal of roentgenology.

[18]  J. Stoker,et al.  The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis , 2010, European Radiology.

[19]  F. Negro,et al.  Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C , 2009, Journal of viral hepatitis.

[20]  A. Lonardo,et al.  Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis. , 2009, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[21]  P. Schulman Bayes' theorem--a review. , 1984, Cardiology clinics.

[22]  Wilfried Philips,et al.  A tissue-specific adaptive texture filter for medical ultrasound images. , 2005, Ultrasound in medicine & biology.

[23]  Peter Whitehead Theorem (review) , 2011 .

[24]  Tariq Hameed,et al.  Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[25]  H. Cortez‐Pinto,et al.  Hepatic steatosis in hepatitis B virus infected patients: Meta‐analysis of risk factors and comparison with hepatitis C infected patients , 2011, Journal of gastroenterology and hepatology.

[26]  P. Vajro,et al.  Diagnosis of Nonalcoholic Fatty Liver Disease in Children and Adolescents: Position Paper of the ESPGHAN Hepatology Committee , 2012, Journal of pediatric gastroenterology and nutrition.

[27]  Chris Day,et al.  A position statement on NAFLD/NASH based on the EASL 2009 special conference. , 2010, Journal of hepatology.

[28]  G. Lau,et al.  Guidelines for the assessment and management of non‐alcoholic fatty liver disease in the Asia–Pacific region: Executive summary , 2007, Journal of gastroenterology and hepatology.

[29]  Ravi Dhar,et al.  Ultrasound Diagnosis of Fatty Liver in Patients With Chronic Liver Disease: A Retrospective Observational Study , 2007, Journal of clinical gastroenterology.

[30]  P. Sundgren,et al.  Magnetic resonance spectroscopy. , 2005, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[31]  V. Wong,et al.  Hepatitis B virus infection and fatty liver in the general population. , 2012, Journal of hepatology.